6:10 PM
 | 
Dec 19, 2013
 |  BC Extra  |  Top Story

Bristol-Myers selling diabetes stake to AZ

AstraZeneca plc (LSE:AZN; NYSE:AZN) will acquire full ownership of the diabetes business it shares with Bristol-Myers Squibb Co. (NYSE:BMY). BMS will receive $2.7 billion up front and is eligible for up to $1.4 billion in regulatory and sales milestones, plus royalties through 2025. BMS reported net sales by the collaboration of $1.2 billion in the first nine months of...

Read the full 284 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >